Difference between revisions of "Template:Adrenergic receptor modulators"

From blackwiki
Jump to navigation Jump to search
blackwiki>Ronhjones
(use listclass = hlist in navbox as per WP:HLIST)
blackwiki>Vanished 45kd09la13
Line 95: Line 95:
 
* [[Upidosin]]
 
* [[Upidosin]]
 
* [[Urapidil]]
 
* [[Urapidil]]
* [[Zolertine]]<br/><small>* Note that many [[tricyclic antidepressant|TCAs]]
+
* [[Zolertine]]<br/><small>* Note that many [[tricyclic antidepressant|TCAs]], [[tetracyclic antidepressants|TeCAs]], [[antipsychotic]]s, [[ergoline]]s, and some [[piperazine]]s like [[buspirone]], [[trazodone]], [[nefazodone]], [[etoperidone]], and [[mepiprazole]] all antagonize α<sub>1</sub>-adrenergic receptors as well, which contributes to their side effects such as [[orthostatic hypotension]].</small>
* [[tetracyclic antidepressants|TeCAs]]
 
* [[antipsychotic]]s, [[ergoline]]s, and some [[piperazine]]s like [[buspirone]]
 
* [[trazodone]]
 
* [[nefazodone]]
 
* [[etoperidone]], and [[mepiprazole]] all antagonize α<sub>1</sub>-adrenergic receptors as well, which contributes to their side effects such as [[orthostatic hypotension]].</small>
 
  
 
     | group2 = [[α2-adrenergic receptor|α<sub>2</sub>]]
 
     | group2 = [[α2-adrenergic receptor|α<sub>2</sub>]]

Revision as of 00:49, 17 April 2012